Several recently published studies and case reports pointed at a failure in antiplatelet response to clopidogrel (the most frequently used ADP receptor blocker in ACS patients) which might be connected with insulin resistance and T2D. Here, P2RY1 is linked to type 2 diabetes mellitus.